Shikonin treatment of LSK leads to apoptosis of CML and IM-treated LSKs compared to the single and dual treated non-transformed LSK (Fig. S6G), consistent with PKM2 knock out of untreated CML cells [24]. The gene discussed is PKM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.